DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Influenza Market - Vaccines and Therapeutics" report to their offering.
The global influenza market is estimated to reach US$10.2 billion by 2022, with a 8.5% CAGR growth during the 2016-2022 period.
The report reviews, analyses and projects the Influenza therapeutics market at the global level while vaccines market is explored in and the regional markets including North America, Europe, Asia-Pacific, South & Central America and Middle East & Africa.
This 128 page market research report includes 30 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. This report profiles 16 key global players and 39 major players across North America - 8; Europe - 10; Asia-Pacific - 20 and South & Central America - 1.
The research also provides the listing of the companies engaged in research and development, manufacturing and supply of influenza vaccines and therapeutic. The global list of companies covers addresses, contact numbers and the website addresses of 80 companies.
Companies Mentioned:
- Abbott Laboratories
- Astrazeneca PLC
- Biocryst Pharmaceuticals, Inc.
- CSL Limited
- Daiichi Sankyo Co., Ltd.
- Glaxosmithkline PLC
- Hualan Biological Engineering Inc.
- Instituto Butantan
- Mitsubishi Tanabe Pharma Corporation
- Nanotherapeutics Inc.
- Protein Sciences Corporation
- Roche Holding AG
- Sanofi SA
- Shanghai Institute of Biological Products Co., Ltd.
- Shionogi & Co., Ltd.
-
Sinovac Biotech Ltd.
Report Structure:
Part A: Global Market Perspective
1. Introduction
2. Major Products In Pipeline
3. Key Market Trends
4. Key Global Players
5. Key Business Trends
6. Global Market Overview
Part B: Regional Market Perspective
Regional Market Overview
1. North America
2. Europe
3. Asia-Pacific
4. South & Central America
5. Middle East & Africa
Part C: Guide To The Industry
1. North America
2. Europe
3. Asia-Pacific
4. Rest Of World
Part D: Annexure
1. Research Methodology
2. Feedback
For more information about this report visit http://www.researchandmarkets.com/research/9dkfmq/global_influenza
